These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 5111320

  • 81. [Comparison of the effect of various antiarrhythmic drugs on the model of experimental epinephrine arrhythmia].
    Vrbovský L.
    Bratisl Lek Listy; 1973 Aug; 60(2):161-74. PubMed ID: 4732262
    [No Abstract] [Full Text] [Related]

  • 82. Suppression of refractory recurrent ventricular tachycardia by transvenous rapid cardiac pacing and antiarrhythmic drugs. Report of seven cases.
    Friedberg CK, Lyon LJ, Donoso E.
    Am Heart J; 1970 Jan; 79(1):44-50. PubMed ID: 5410281
    [No Abstract] [Full Text] [Related]

  • 83. Cellular basis of cardiac dysrhythmias.
    Williams EM.
    Adv Cardiol; 1974 Jan; 12(0):256-65. PubMed ID: 4151858
    [No Abstract] [Full Text] [Related]

  • 84. A new series of antiarrhythmic agents. The 2-aminotetralins.
    Graeff DM, Johnson WE, Saint Dennis CD, Martin AR.
    J Med Chem; 1971 Jan; 14(1):60-2. PubMed ID: 5539752
    [No Abstract] [Full Text] [Related]

  • 85. Mechanisms contributing to dysrhythmias induced by ischemia and their therapeutic implications.
    Corr PB, Sobel BE.
    Adv Cardiol; 1978 Jan; (22):110-29. PubMed ID: 22992
    [No Abstract] [Full Text] [Related]

  • 86. Acute coronary artery occlusion-reperfusion-induced arrhythmias in rats, dogs and pigs: antiarrhythmic evaluation of quinidine, procainamide and lidocaine.
    Bergey JL, Nocella K, McCallum JD.
    Eur J Pharmacol; 1982 Jul 09; 81(2):205-16. PubMed ID: 7117374
    [Abstract] [Full Text] [Related]

  • 87. Intracardiac electrophysiologic studies as a method for the optimization of drug therapy in chronic ventricular arrhythmia.
    Horowitz LN, Josephson ME, Kastor JA.
    Prog Cardiovasc Dis; 1980 Jul 09; 23(2):81-98. PubMed ID: 6997925
    [No Abstract] [Full Text] [Related]

  • 88. Effect of SU 13197, a new antiarrhythmic agent, on atrial arrhythmias: preliminary study.
    Dreifus LS, Lim HF, Rabbino MD, Watanabe Y.
    Am J Cardiol; 1968 Apr 09; 21(4):544-8. PubMed ID: 5645997
    [No Abstract] [Full Text] [Related]

  • 89. Prevention of sudden coronary death by chronic antiarrhythmic therapy.
    Koch-Weser J.
    Adv Cardiol; 1978 Apr 09; 25():206-28. PubMed ID: 360790
    [No Abstract] [Full Text] [Related]

  • 90. Guide to managing digitalis intoxication.
    Chung EK.
    Postgrad Med; 1971 Feb 09; 49(2):99-101. PubMed ID: 5540806
    [No Abstract] [Full Text] [Related]

  • 91. A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol.
    Basil B, Jordan R, Loveless AH, Maxwell DR.
    Br J Pharmacol; 1974 Mar 09; 50(3):323-33. PubMed ID: 4850183
    [Abstract] [Full Text] [Related]

  • 92. Broad sensitivity of rodent arrhythmia models to class I, II, III, and IV antiarrhythmic agents.
    Brooks RR, Miller KE, Carpenter JF, Jones SM.
    Proc Soc Exp Biol Med; 1989 Jun 09; 191(2):201-9. PubMed ID: 2726785
    [Abstract] [Full Text] [Related]

  • 93. [Antiarrhythmic effect of the diethylaminoethylamide of dehydroabietic acid (substance E-25), quinidine and procaine amide in arrhythmia in anesthetized dogs, induced by K-strophanthin].
    Vrbovský L.
    Bratisl Lek Listy; 1971 Jun 09; 56(2):161-79. PubMed ID: 5156932
    [No Abstract] [Full Text] [Related]

  • 94. [Relative effectiveness of various antiarrhythmia drugs in experimental aconitine arrhythmia].
    Vrbovský L.
    Bratisl Lek Listy; 1971 Jun 09; 56(6):669-80. PubMed ID: 5157092
    [No Abstract] [Full Text] [Related]

  • 95. Clinical pharmacokinetics of antiarrhythmic drugs.
    Harrison DC, Meffin PJ, Winkle RA.
    Prog Cardiovasc Dis; 1977 Jun 09; 20(3):217-42. PubMed ID: 335439
    [No Abstract] [Full Text] [Related]

  • 96. Antiarrhythmic effects of dichloroisoprenaline, H 56-28, ICI 50172, LB 46, MJ 1999 and propranolol on aconitine-induced atrial and ouabain-induced ventricular arrhythmias.
    Hashimoto K, Nakayama K, Oshima T, Kumakura S.
    Experientia; 1971 Jun 09; 27(6):666-7. PubMed ID: 4397569
    [No Abstract] [Full Text] [Related]

  • 97. The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.
    Allen JD, Ekue JM, Shanks RG, Zaidi SA.
    Br J Pharmacol; 1972 Aug 09; 45(4):561-73. PubMed ID: 5085230
    [Abstract] [Full Text] [Related]

  • 98. The antiarrhythmic properties of BL-3677A.
    Buyniski JP, Gardier RW.
    J Pharmacol Exp Ther; 1974 Aug 09; 190(2):289-99. PubMed ID: 4449041
    [No Abstract] [Full Text] [Related]

  • 99. [Combined action of anaprilin with quinidine and phentolamine in strophanthin arrhythmia].
    Gorodinskaia VIa, Berzon ETs.
    Farm Zh; 1974 Aug 09; 29(5):73-7. PubMed ID: 4463095
    [No Abstract] [Full Text] [Related]

  • 100. The efficacy of antiarrhythmic drugs in the prevention of recurrence of aconitine-induced atrial fibrillation after electrical conversion.
    Byrne JE, Dresel PE.
    Can J Physiol Pharmacol; 1970 Feb 09; 48(2):90-7. PubMed ID: 4391942
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.